CorMedix Therapeutics Email Format
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
CorMedix Therapeutics is a biopharmaceutical company in the pharmaceutical manufacturing industry focused on developing and commercializing products for the prevention and treatment of infectious and inflammatory diseases. Its lead product, DefenCath, is an antibacterial and antifungal solution designed to prevent bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has FDA Fast Track designation and Qualified Infectious Disease Product designation, and the company’s NDA received priority review. The company is headquartered in Berkeley Heights, New Jersey, at 300 Connell Drive, Suite 4200, 07922, and it employs between 51 and 200 people. Further information is available at the company website, https://cormedix.com.